A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio Seeks to Protect American Investors From Chinese Deception
The People’s Republic of China (PRC) reportedly ordered Chinese law firms to conceal information about the risks of doing business in the PRC from American investors. This coverup is part of the PRC’s ongoing campaign to crack down on the private sector and restrict access to information about the Chinese economy. Despite their government intentionally breaking our laws and deceiving American investors, Chinese companies can still access U.S. capital markets.
U.S. Senator Marco Rubio (R-FL) sent a letter to U.S. Securities and Exchange Commission Chairman Gary Gensler inquiring about what the SEC will do to ensure American investors are informed about the real and serious risks of investing in China.
- “Beijing’s efforts at coercion and concealment naturally raise the question of what it is trying to hide—or what it is preparing for in secret. What is clear is that the CCP is enlisting Chinese firms in a conspiracy to violate U.S. law and thwart U.S. securities regulators.”
The full text of the letter is below.
Dear Chairman Gensler:
I write with regard to disturbing news that the People’s Republic of China (PRC) is pressuring firms to conceal information about the risks of doing business in the PRC. If true, this effort is a direct challenge to American law and securities regulations. I trust that you will take the strongest possible measures to protect American investors and credibility by ensuring that Chinese firms are complying with our laws, and, if they fail to do so, barring them from U.S. capital markets.
On July 20, 2023, the Chinese Securities Regulatory Commission (CSRC) reportedly convened a secret meeting with ten Chinese law firms, including Fangda Partners, Han Kun Law Offices, and Zhong Lun Law Firm, to offer informal guidance about Chinese firms seeking initial public offerings (IPOs) overseas. According to Reuters, the CSRC commanded law firms not to sign off on offshore IPO documents that disclose the risks of doing business in the PRC, such as the tyrannical rule of the Chinese Communist Party (CCP), its sweeping “national security” laws, the instability of the Chinese economy, and the arbitrariness of the Chinese judicial system.
The CSRC’s latest directive expands on a March 2023 rule that requires Chinese companies to comply with the PRC’s national-security laws in order to list overseas. That rule also prohibits companies from making statements in their prospectuses that “misrepresent or disparage laws and policies, business environment and judicial situation” in the PRC. Effectively, the rule forbids companies from speaking ill about the CCP and its oppressive regime. The CSRC threatened to block Chinese companies from listing overseas if they alert investors to these real and serious risks.
Beijing’s directive to Chinese law firms is part of a broader campaign to crack down on the private sector and conceal information from Western investors. Late last year, the Cyberspace Administration of China ordered Wind Information Co., the PRC’s equivalent of the Bloomberg Terminal, to restrict financial data about Chinese companies for offshore users. In February, China’s Ministry of Finance instructed state-owned enterprises to phase out Western auditing firms in favor of more pliable local firms. In April, the CCP expanded its Counter Espionage Law to encompass not only “state secrets,” but any “documents, data, materials or items related to national security and interests”—an expansion that imperils any company or employee working in sectors deemed sensitive by Beijing. Chinese authorities also have shut down, fined, or raided a number of Western investment and consulting firms this year alone. Unfortunately, these provocations have not convinced Wall Street firms and multinational corporations to stop collaborating with the CCP. Late last month, KKR, Blackstone, and Carlyle reportedly met with Chinese securities regulators to ensure their access to the country
Beijing’s efforts at coercion and concealment naturally raise the question of what it is trying to hide—or what it is preparing for in secret. What is clear is that the CCP is enlisting Chinese firms in a conspiracy to violate U.S. law and thwart U.S. securities regulators. My Uyghur Forced Labor Prevention Act (UFLPA), together with the Holding Foreign Companies Accountable Act (HFCAA), requires Chinese companies to disclose their ties to the CCP, the risks of doing business in the PRC, and their compliance with the UFLPA. The SEC has provided guidance elaborating on these disclosure requirements. Now, the CCP is instructing its firms to ignore those disclosure requirements and violate our laws. Such a challenge to U.S. authority and threat to U.S. investors demands a response. I offer the following questions to determine what the SEC believes that response should be.
- Do you believe that Chinese companies that fail to disclose the risks of doing business in the PRC should be allowed to access American markets?
- What steps will the SEC take to ensure that Chinese firms seeking to access American markets do not censor their prospectuses under pressure from the CCP?
- Do you believe that any Chinese firm should be allowed to list on U.S. stock exchanges, given the obvious pressure from Beijing to conceal information and deceive American investors?
- Should Western investors feel any confidence, when they invest in the PRC, that their capital is safe and they know what they are purchasing?
- What steps is the SEC taking to require Wall Street firms and multinational corporations to disclose their collaboration with the CCP?
- Do you believe that public pension funds, such as the Thrift Savings Plan, should be allowed to invest Americans’ retirement savings or offer investments in PRC firms?
- What information do you believe corporate disclosures must contain in order to ensure enforcement of the UFLPA?
Thank you for your consideration and for your prompt response to these important issues.
Sincerely,